Biomaterials for drug delivery patches
The limited efficiency of conventional drugs has been instigated the development of new and more effective drug delivery systems (DDS). Transdermal DDS, are associated with numerous advantages such its painless application and less frequent replacement and greater flexibility of dosing, features tha...
Gespeichert in:
Veröffentlicht in: | European journal of pharmaceutical sciences 2018-06, Vol.118, p.49-66 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 66 |
---|---|
container_issue | |
container_start_page | 49 |
container_title | European journal of pharmaceutical sciences |
container_volume | 118 |
creator | Santos, Lúcia F. Correia, Ilídio J. Silva, A. Sofia Mano, João F. |
description | The limited efficiency of conventional drugs has been instigated the development of new and more effective drug delivery systems (DDS). Transdermal DDS, are associated with numerous advantages such its painless application and less frequent replacement and greater flexibility of dosing, features that triggered the research and development of such devices. Such systems have been produced using either biopolymer; or synthetic polymers. Although the first ones are safer, biocompatible and present a controlled degradation by human enzymes or water, the second ones are the most currently available in the market due to their greater mechanical resistance and flexibility, and non-degradation over time. This review highlights the most recent advances (mainly in the last five years) of patches aimed for transdermal drug delivery, focusing on the different materials (natural, synthetic and blends) and latest designs for the development of such devices, emphasizing also their combination with drug carriers that enable enhanced drug solubility and a more controlled release of the drug over the time. The benefits and limitations of different patches formulations are considered with reference to their appliance to transdermal drug delivery. Furthermore, a record of the currently available patches on the market is given, featuring their most relevant characteristics. Finally, a list of most recent/ongoing clinical trials regarding the use of patches for skin disorders is detailed and critical insights on the current state of patches for transdermal drug delivery are also provided.
[Display omitted] |
doi_str_mv | 10.1016/j.ejps.2018.03.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2018025604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098718301350</els_id><sourcerecordid>2018025604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-7f1e827b4be8022a13e30b030f29bebaec1f7cb1fef56148b75dfb3db54ae9543</originalsourceid><addsrcrecordid>eNp9kL1OwzAYRS0EoqXwAgwoE2JJ-Oz82JFYoOJPqsQCs2U7n8FRQoKdVurbk9DCyHSXc690DyHnFBIKtLiuE6z7kDCgIoE0AQYHZE4FL2PgDA7JHEomYigFn5GTEGoAKASHYzJjZc4ZLWBOLu9c16oBvVNNiGzno8qv36MKG7dBv416NZgPDKfkyI4Anu1zQd4e7l-XT_Hq5fF5ebuKTZoXQ8wtRcG4zjQKYEzRFFPQkIJlpUat0FDLjaYWbV7QTGieV1anlc4zhWWepQtytdvtffe1xjDI1gWDTaM-sVsHOX0FlhcwoWyHGt-F4NHK3rtW-a2kICc_spaTn5-OhFSOfsbSxX5_rVus_iq_QkbgZgfg-HLj0MtgHH4arJxHM8iqc__tfwNWTXYW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2018025604</pqid></control><display><type>article</type><title>Biomaterials for drug delivery patches</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><creator>Santos, Lúcia F. ; Correia, Ilídio J. ; Silva, A. Sofia ; Mano, João F.</creator><creatorcontrib>Santos, Lúcia F. ; Correia, Ilídio J. ; Silva, A. Sofia ; Mano, João F.</creatorcontrib><description>The limited efficiency of conventional drugs has been instigated the development of new and more effective drug delivery systems (DDS). Transdermal DDS, are associated with numerous advantages such its painless application and less frequent replacement and greater flexibility of dosing, features that triggered the research and development of such devices. Such systems have been produced using either biopolymer; or synthetic polymers. Although the first ones are safer, biocompatible and present a controlled degradation by human enzymes or water, the second ones are the most currently available in the market due to their greater mechanical resistance and flexibility, and non-degradation over time. This review highlights the most recent advances (mainly in the last five years) of patches aimed for transdermal drug delivery, focusing on the different materials (natural, synthetic and blends) and latest designs for the development of such devices, emphasizing also their combination with drug carriers that enable enhanced drug solubility and a more controlled release of the drug over the time. The benefits and limitations of different patches formulations are considered with reference to their appliance to transdermal drug delivery. Furthermore, a record of the currently available patches on the market is given, featuring their most relevant characteristics. Finally, a list of most recent/ongoing clinical trials regarding the use of patches for skin disorders is detailed and critical insights on the current state of patches for transdermal drug delivery are also provided.
[Display omitted]</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2018.03.020</identifier><identifier>PMID: 29572160</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Drug carriers ; Drug delivery systems ; Patches ; Polymers ; Skin ; Transdermal delivery</subject><ispartof>European journal of pharmaceutical sciences, 2018-06, Vol.118, p.49-66</ispartof><rights>2018</rights><rights>Copyright © 2018. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-7f1e827b4be8022a13e30b030f29bebaec1f7cb1fef56148b75dfb3db54ae9543</citedby><cites>FETCH-LOGICAL-c356t-7f1e827b4be8022a13e30b030f29bebaec1f7cb1fef56148b75dfb3db54ae9543</cites><orcidid>0000-0002-5388-1732</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejps.2018.03.020$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29572160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Santos, Lúcia F.</creatorcontrib><creatorcontrib>Correia, Ilídio J.</creatorcontrib><creatorcontrib>Silva, A. Sofia</creatorcontrib><creatorcontrib>Mano, João F.</creatorcontrib><title>Biomaterials for drug delivery patches</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>The limited efficiency of conventional drugs has been instigated the development of new and more effective drug delivery systems (DDS). Transdermal DDS, are associated with numerous advantages such its painless application and less frequent replacement and greater flexibility of dosing, features that triggered the research and development of such devices. Such systems have been produced using either biopolymer; or synthetic polymers. Although the first ones are safer, biocompatible and present a controlled degradation by human enzymes or water, the second ones are the most currently available in the market due to their greater mechanical resistance and flexibility, and non-degradation over time. This review highlights the most recent advances (mainly in the last five years) of patches aimed for transdermal drug delivery, focusing on the different materials (natural, synthetic and blends) and latest designs for the development of such devices, emphasizing also their combination with drug carriers that enable enhanced drug solubility and a more controlled release of the drug over the time. The benefits and limitations of different patches formulations are considered with reference to their appliance to transdermal drug delivery. Furthermore, a record of the currently available patches on the market is given, featuring their most relevant characteristics. Finally, a list of most recent/ongoing clinical trials regarding the use of patches for skin disorders is detailed and critical insights on the current state of patches for transdermal drug delivery are also provided.
[Display omitted]</description><subject>Drug carriers</subject><subject>Drug delivery systems</subject><subject>Patches</subject><subject>Polymers</subject><subject>Skin</subject><subject>Transdermal delivery</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kL1OwzAYRS0EoqXwAgwoE2JJ-Oz82JFYoOJPqsQCs2U7n8FRQoKdVurbk9DCyHSXc690DyHnFBIKtLiuE6z7kDCgIoE0AQYHZE4FL2PgDA7JHEomYigFn5GTEGoAKASHYzJjZc4ZLWBOLu9c16oBvVNNiGzno8qv36MKG7dBv416NZgPDKfkyI4Anu1zQd4e7l-XT_Hq5fF5ebuKTZoXQ8wtRcG4zjQKYEzRFFPQkIJlpUat0FDLjaYWbV7QTGieV1anlc4zhWWepQtytdvtffe1xjDI1gWDTaM-sVsHOX0FlhcwoWyHGt-F4NHK3rtW-a2kICc_spaTn5-OhFSOfsbSxX5_rVus_iq_QkbgZgfg-HLj0MtgHH4arJxHM8iqc__tfwNWTXYW</recordid><startdate>20180615</startdate><enddate>20180615</enddate><creator>Santos, Lúcia F.</creator><creator>Correia, Ilídio J.</creator><creator>Silva, A. Sofia</creator><creator>Mano, João F.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5388-1732</orcidid></search><sort><creationdate>20180615</creationdate><title>Biomaterials for drug delivery patches</title><author>Santos, Lúcia F. ; Correia, Ilídio J. ; Silva, A. Sofia ; Mano, João F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-7f1e827b4be8022a13e30b030f29bebaec1f7cb1fef56148b75dfb3db54ae9543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Drug carriers</topic><topic>Drug delivery systems</topic><topic>Patches</topic><topic>Polymers</topic><topic>Skin</topic><topic>Transdermal delivery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Santos, Lúcia F.</creatorcontrib><creatorcontrib>Correia, Ilídio J.</creatorcontrib><creatorcontrib>Silva, A. Sofia</creatorcontrib><creatorcontrib>Mano, João F.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Santos, Lúcia F.</au><au>Correia, Ilídio J.</au><au>Silva, A. Sofia</au><au>Mano, João F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomaterials for drug delivery patches</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2018-06-15</date><risdate>2018</risdate><volume>118</volume><spage>49</spage><epage>66</epage><pages>49-66</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>The limited efficiency of conventional drugs has been instigated the development of new and more effective drug delivery systems (DDS). Transdermal DDS, are associated with numerous advantages such its painless application and less frequent replacement and greater flexibility of dosing, features that triggered the research and development of such devices. Such systems have been produced using either biopolymer; or synthetic polymers. Although the first ones are safer, biocompatible and present a controlled degradation by human enzymes or water, the second ones are the most currently available in the market due to their greater mechanical resistance and flexibility, and non-degradation over time. This review highlights the most recent advances (mainly in the last five years) of patches aimed for transdermal drug delivery, focusing on the different materials (natural, synthetic and blends) and latest designs for the development of such devices, emphasizing also their combination with drug carriers that enable enhanced drug solubility and a more controlled release of the drug over the time. The benefits and limitations of different patches formulations are considered with reference to their appliance to transdermal drug delivery. Furthermore, a record of the currently available patches on the market is given, featuring their most relevant characteristics. Finally, a list of most recent/ongoing clinical trials regarding the use of patches for skin disorders is detailed and critical insights on the current state of patches for transdermal drug delivery are also provided.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>29572160</pmid><doi>10.1016/j.ejps.2018.03.020</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-5388-1732</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0928-0987 |
ispartof | European journal of pharmaceutical sciences, 2018-06, Vol.118, p.49-66 |
issn | 0928-0987 1879-0720 |
language | eng |
recordid | cdi_proquest_miscellaneous_2018025604 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings |
subjects | Drug carriers Drug delivery systems Patches Polymers Skin Transdermal delivery |
title | Biomaterials for drug delivery patches |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A26%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomaterials%20for%20drug%20delivery%20patches&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Santos,%20L%C3%BAcia%20F.&rft.date=2018-06-15&rft.volume=118&rft.spage=49&rft.epage=66&rft.pages=49-66&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2018.03.020&rft_dat=%3Cproquest_cross%3E2018025604%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2018025604&rft_id=info:pmid/29572160&rft_els_id=S0928098718301350&rfr_iscdi=true |